Skip to Content

Mepivacaine Injection

Last Updated: January 10, 2018
Status: Resolved

Mepivacaine Injection

Products Affected - Description
  • Carbocaine injection, Pfizer
    1%, 30 mL preservative-free vial (NDC 00409-1036-30)

1%, 50 mL multiple dose vial (NDC 00409-1038-50)
1.5%, 30 mL preservative-free vial (NDC 00409-1041-30)
2%, 50 mL multiple dose vial (NDC 00409-2047-50)
Reason for the Shortage
    • Fresenius Kabi has Polocaine and Polocaine-MPF available.
    • Pfizer states the reason for the shortage is manufacturing delays.
Available Products
  • Carbocaine injection, Pfizer
    2%, 20 mL preservative-free vial (NDC 00409-1067-20)

 
Polocaine injection, Fresenius Kabi
1%, 50 mL multiple dose vial (NDC 63323-0283-57)
2%, 50 mL multiple dose vial (NDC 63323-0296-57)
 
Polocaine-MPF injection, Fresenius Kabi
1%, 30 mL preservative-free vial (NDC 63323-0260-37)
1.5%, 30 mL preservative-free vial (NDC 63323-0293-37)
2%, 20 mL preservative-free vial (NDC 63323-0294-27)

Estimated Resupply Dates

    • Pfizer has Carbocaine 1% 50 mL multiple-dose vials on back order and the company estimates a release date of mid-February 2018. Carbocaine 1% 30 mL preservative-free vials are available in limited supply. Carbocaine 1.5% 30 mL preservative-free vials are on back order and the company estimates a release date of March 2019. Carbocaine 2% 50 mL multiple-dose vials are back order and the company estimates a release date of early-February 2018.

Updated

January 10, 2018; December 8 and 5, November 22 and 7, October 2, September 26, 13 and 5, July 31, 25 and 11, June 20 and 9, 2017, University of Utah, Drug Information Service. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide